Application no. and date | 11727917.4 (espacenet) (Federated) (European Patent Register), 20110601 | Patent/reg. no. and date | DK/EP 2575785, 20221026 | Publication date | 20130410 | Priority no. and date | EP 10005762, 20100602, EP 11075046, 20110314 | EP pub. no. and date |
EP 2575785 20130410 | Effective date | | Applicant/owner | Pharma& Schweiz GmbH, Riedstrasse 1
6330 Cham, CH | Applicant ref. no. | 167651/BT/GP | Inventor | PATZAK, Ulrich, Astellas Pharma Europe BV PO Box 344
2300 AH Leiden, NL, OUATAS, Taoufik, Astellas Pharma Europe BV PO Box 344
2300 AH Leiden, NL | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/573 (2006.01) , A61K 47/10 (2017.01) , A61K 9/14 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | Title | Orale doseringsformer af bendamustin og terapeutisk anvendelse deraf | Int. application no. | EP2011002763 | Int. publication no. | WO2011151086 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|